title: Changes in blood coagulation-related parameters in phenobarbital-treated rabbits.
abstract: The effects of repeated administration of phenobarbital (PB) on blood coagulation time were examined using male Japanese white SPF rabbits, which are widely used for toxicological studies. PB was administered to the rabbits by oral gavage for 2 weeks, at dose levels of 0, 12.5, 25 and 50 mg/kg/day. Blood was collected on Days 8 and 14 after each day's dosing to perform blood coagulation examination. The liver was excised, weighed and examined histopathologically. Activated partial thromboplastin time (APTT) was prolonged at dose levels of 12.5 mg/kg/day or more and Thrombotest (TBT) was prolonged at 50 mg/kg/day on Day 8. APTT was prolonged at dose levels of 12.5 mg/kg/day or more, TBT was prolonged at 25 mg/kg/day or more and factor IX activity decreased at 50 mg/kg/day on Day 14. At pathological examination, liver weight increased at dose levels of 25 mg/kg/day or more, and a ground-glass appearance of the hepatocytes was observed in the central and middle parts of lobules at 12.5 mg/kg/day or more. However, changes in factor VII or X activity or prolongation of prothrombin time (PT) were not observed. Therefore, prolongation of blood coagulation time by PB administration in rabbits was considered to be due to PB's effect on the endogenous pathway alone. Moreover, an increase in anti-thrombin III (ATIII) concentration was noted at 50 mg/kg/day; however, no change was noted at dose levels of 25 mg/kg/day or less. This suggests that the contribution of ATIII to the PB-induced prolongation of coagulation time in rabbits was small.
authors: Bozo Research Center Inc., Shizuoka 412-0039, Japan. mochizuki@bozo.co.jp
authors: Masahiro
authors: M
authors: Mochizuki
authors: Hajime
authors: H
authors: Abe
authors: Kei
authors: K
authors: Wakabayashi
authors: Hiroyasu
authors: H
authors: Yoshinaga
authors: Emi
authors: E
authors: Okazaki
authors: Tsubasa
authors: T
authors: Saito
authors: Mariko
authors: M
authors: Fujita
authors: Hiroshi
authors: H
authors: Edamoto
authors: Yuzo
authors: Y
authors: Asano
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000990:Antithrombin III / Q000378:metabolism; D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005164:Factor IX / Q000378:metabolism; D005167:Factor VII / Q000378:metabolism; D005170:Factor X / Q000378:metabolism; D008099:Liver / Q000473:pathology; D008297:Male; D010314:Partial Thromboplastin Time; D010634:Phenobarbital / Q000008:administration & dosage / Q000633:toxicity*; D011517:Prothrombin Time; D011817:Rabbits
chemical_list: D001779:Blood Coagulation Factors; D000990:Antithrombin III; D005167:Factor VII; D005164:Factor IX; D005170:Factor X; D010634:Phenobarbital